- Jul 2018
-
europepmc.org europepmc.org
-
On 2015 Jul 20, David Keller commented:
Why have these benefits not been reported by Parkinson disease patients taking these anti-malarials?
I am skeptical about this report for the following reason: chloroquine is an old anti-malarial drug which must have been taken by many Parkinson's disease patients over the decades. If the benefits in humans are similar to those reported in the rat model, then surely it would have been observed and reported before. How do the authors explain this apparent contradiction?
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-
- Feb 2018
-
europepmc.org europepmc.org
-
On 2015 Jul 20, David Keller commented:
Why have these benefits not been reported by Parkinson disease patients taking these anti-malarials?
I am skeptical about this report for the following reason: chloroquine is an old anti-malarial drug which must have been taken by many Parkinson's disease patients over the decades. If the benefits in humans are similar to those reported in the rat model, then surely it would have been observed and reported before. How do the authors explain this apparent contradiction?
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.
-